Replies to post #388830 on Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

"I think it depends on how one wants to read it."

Nah, it's an outright lie.

Brilacidin failed its primary endpoint in this study, and in the process all the secondary endpoints were automatically rendered moot.

And all the retrospective data dredging amounts to nothing other than painting targets round bulletholes after the bullets missed the actual bullseye by miles.

I'm afraid that the statement:

"Brilacidin showed promising treatment effects"

is unequivocally false, and as such probably constitutes securities fraud.